Tetrahedron Letters
Furan ring opening–pyrrole ring closure. A simple route
to 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-3-ones
c
d
d
Igor V. Trushkov a,b, , Tatyana A. Nevolina , Vitaly A. Shcherbinin , Lyudmila N. Sorotskaya ,
⇑
Alexander V. Butin c,d,
⇑
a Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russian Federation
b Laboratory of Chemical Synthesis, Federal Research Center of Pediatric Hematology, Oncology and Immunology, Samory Mashela 1, Moscow 117997, Russian Federation
c Perm State University, Bukireva 15, Perm 614990, Russian Federation
d Research Institute of Heterocyclic Compounds Chemistry, Kuban State Technological University, Moskovskaya St. 2, Krasnodar 350072, Russian Federation
a r t i c l e i n f o
a b s t r a c t
Article history:
We report here an application of a furan ring opening-Paal–Knorr pyrrole synthesis sequence for the
transformation of furfurylamines into 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-3-ones.
Ó 2013 Elsevier Ltd. All rights reserved.
Received 26 March 2013
Revised 6 May 2013
Accepted 17 May 2013
Available online xxxx
Keywords:
Furans
1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazines
Ring opening
Ring closure
Recyclization
Pyrrole derivatives represent a very important class of hetero-
cyclic compounds.1 Among them, pyrroles annulated to other het-
erocycles via a C–N bond can be highlighted due to the broad
spectrum of their bioactivity. The antitumor and antibiotic agent,
mitomycin is a pyrrolo[1,2-a]indole derivative, whilst the anti-
HIV agent castanospermine has an indolizidine scaffold; Erythrina
alkaloids belong to pyrrolo[2,1-a]isoquinoline family; and the pyr-
rolo[1,2-b]isoquinoline fragment is present in Amaryllidaceae alka-
loids. Aptazapine, bretazenil, ketorolac, and other drugs also
contain a pyrrole moiety, the C–N bond of which is annulated to
another ring(s).
various heterocycles based on furan recyclizations,9 we applied
this method for the preparation of 1,2,3,4-tetrahydropyrrolo[1,2-
a]pyrazines.10,11 This fragment is present in natural compounds
(e.g., the antibacterial longamide A, the antiprotozoal longamide
B, cytotoxic agelastatin A, and palau’amine, etc.), as well as in syn-
thetic drugs, such as ranirestat which is utilized for the treatment
of diabetic neuropathy (Fig 1).12
Relying on our previous experience,2,6,7 we designed a route to
1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-3-ones 1 as depicted in
Scheme 1. The pyrrolo[1,2-a]pyrazine core can be obtained by an
acid-catalyzed recyclization of N-furfurylamides of
a-amino acids
All syntheses of these compounds can be divided into three
main groups: (a) cyclizations of functionalized pyrroles affording
annulated azaheterocycles; (b) formation of pyrrole rings in com-
pounds containing an azaheterocycle; (c) simultaneous formation
of both rings. The third group includes recyclization of appropri-
ately substituted furans. The last approach was utilized to prepare
5-alkyl-2-aminomethylpyrroles,2 indoles,3 isoindoles,4 pyrrol-
o[2,3-d]pyridazines,5 pyrrolo[1,2-a][1,4]diazepines,6 pyrrolo[1,2-
d][1,4]diazepines,7 and other pyrrole ring-containing polycyclic
systems.8 In continuation of our program on the synthesis of
Br
Br
Br
O
H
N
HO
N
N
X
NH
H3C
O
N
H
O
H
N
H
X = OH: longamide A
H
X = CH2CO2H: longamide B
X = CH2CO2Et: hanishin
agelastatin A
O
H
H
N
HN
N
N
H
N
O
H2N
HO
HN
N
O
O
N
O
⇑
Corresponding authors. Fax: +7 342 237 1480 (A.V.B.).
H2N
N
NH2
Br
F
Cl
palau'amine
ranirestat
0040-4039/$ - see front matter Ó 2013 Elsevier Ltd. All rights reserved.
Fig. 1. Several bioactive 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines.